- Home
- SABS vs KFFB Comparison
SABS vs KFFB Comparison
Compare SABS & KFFB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SABS
- KFFB
- Stock Information
- Founded
- SABS 2014
- KFFB 2005
- Country
- SABS United States
- KFFB United States
- Employees
- SABS N/A
- KFFB N/A
- Industry
- SABS Biotechnology: Pharmaceutical Preparations
- KFFB Savings Institutions
- Sector
- SABS Health Care
- KFFB Finance
- Exchange
- SABS Nasdaq
- KFFB Nasdaq
- Market Cap
- SABS 23.9M
- KFFB 24.1M
- IPO Year
- SABS N/A
- KFFB 2005
- Fundamental
- Price
- SABS $3.34
- KFFB $2.66
- Analyst Decision
- SABS Strong Buy
- KFFB
- Analyst Count
- SABS 5
- KFFB 0
- Target Price
- SABS $12.40
- KFFB N/A
- AVG Volume (30 Days)
- SABS 83.3K
- KFFB 7.9K
- Earning Date
- SABS 11-06-2024
- KFFB 02-10-2025
- Dividend Yield
- SABS N/A
- KFFB N/A
- EPS Growth
- SABS N/A
- KFFB N/A
- EPS
- SABS N/A
- KFFB N/A
- Revenue
- SABS $1,512,723.00
- KFFB $7,475,000.00
- Revenue This Year
- SABS N/A
- KFFB N/A
- Revenue Next Year
- SABS N/A
- KFFB N/A
- P/E Ratio
- SABS N/A
- KFFB N/A
- Revenue Growth
- SABS N/A
- KFFB N/A
- 52 Week Low
- SABS $2.16
- KFFB $2.50
- 52 Week High
- SABS $7.70
- KFFB $4.83
- Technical
- Relative Strength Index (RSI)
- SABS 48.06
- KFFB 45.83
- Support Level
- SABS $2.75
- KFFB $2.75
- Resistance Level
- SABS $4.30
- KFFB $3.00
- Average True Range (ATR)
- SABS 0.51
- KFFB 0.14
- MACD
- SABS 0.03
- KFFB 0.01
- Stochastic Oscillator
- SABS 26.11
- KFFB 19.05
About SABS SAB Biotherapeutics Inc.
SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.
About KFFB Kentucky First Federal Bancorp
Kentucky First Federal Bancorp is a holding company. The company through its subsidiaries is engaged mainly in the business of accepting deposits from the general public and using such funds to originate loans secured by first mortgages on owner-occupied, residential real estate and other loans secured by real estate. Its primary products and services include Residential mortgage loans, Multi-family loans, Construction loans and types of deposits, etc. The company mainly operates in Perry, Franklin, Boyle and Garrard and surrounding counties in Kentucky, US.